Guangzhou Wondfo Biotech Co.,Ltd (300482.SZ) SHZ

Currency In CNY

AD

Valuation

Market Cap9.57B
Enterprise Value9.12B
P/E Ratio-128.95
PEG Ratio1.71
Price/Sales Ratio3.81
Price/Book Ratio1.38
Enterprise/Revenue3.71
Enterprise/EBITDA69.97

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterSeptember 30, 2026

Profitability

Profit Margin-0.03
Operating Margin-0.02
AD

Management Effectiveness

Return On Assets-0.01
Return On Equity-0.01

Income Statement

Revenue2.09B
Revenue/Share4.21
Gross Profit1.19B
EBITDA179.91M
Net Income-63.02M
Diluted EPS-0.13

Balance Sheet

Total Cash1.47B
Total Cash/Share3.16
Total Debt63.74M
Total Debt/Equity0.01
Current Ratio7.34
Book Value Per Share11.72

Price History

52-Week Change-27.71
52-Week High26.29
52-Week Low15.05
Moving Average 50 Days16.27
Moving Average 200 Days17.81

Statistics

Average Volume5.42M
Shares Outstanding468.15M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0.22
Trailing Annual Dividend Yield1.38
Payout Ratio-2.49
Last Split Factor13:10
Last Split DateMay 26, 2021
AD